Pine Biotech Funding: How Much Did They Raise & Key Investors

How Much Did Pine Biotech Raise?
Funding & Key Investors

Pine Biotech has solidified its position in the life sciences sector, securing a total capital infusion of $1M to accelerate its mission of democratizing complex biomedical data analysis. This recent strategic investment of $1M marks a pivotal moment for the organization, as it transitions from a specialized research-focused entity into a scalable provider of high-performance multi-omics solutions. By bridging the gap between raw data and actionable scientific discovery, the company is effectively addressing the growing demand for accessible bioinformatics tools in both academic and clinical environments.

The firm's growth trajectory, underscored by its foundational work at the Tauber Bioinformatics Research Center, reflects a robust commitment to integrating high-performance computing with intuitive user interfaces. As the industry shifts toward data-intensive research, Pine Biotech remains at the forefront of this transformation, leveraging its proprietary AI technology to simplify the interpretation of disparate biological datasets for a global user base.

What is Pine Biotech?

Pine Biotech

Software

Healthcare Software

Education

Pine Biotech operates at the intersection of advanced computational biology and educational technology. Its flagship platform, T-BioInfo, serves as a comprehensive multi-omics environment that enables researchers and students to perform sophisticated analyses without requiring extensive programming expertise. By embedding machine learning capabilities directly into the research workflow, the company reduces the barrier to entry for complex genomic and proteomic studies. Furthermore, the OmicsLogic curriculum provides a structured pathway for professional development, offering diploma certifications in partnership with leading global universities. This dual-pronged approach—combining powerful research infrastructure with a scalable educational framework—positions Pine Biotech as a critical enabler of modern scientific discovery, particularly in regions where bioinformatics expertise is in high demand.

How much funding has Pine Biotech raised?

Pine Biotech has raised a total of $1M across 1 funding round:

2017

Unspecified

$1M

Unspecified (2017): $1M, investors not publicly disclosed

Key Investors in Pine Biotech

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Pine Biotech?

With the recent capital injection, Pine Biotech is well-positioned to scale its operations and expand its footprint across international research markets. The strategic roadmap likely involves enhancing the T-BioInfo platform's AI-driven analytical depth while simultaneously broadening the reach of its university-affiliated certification programs. As the company continues to foster collaborations with research institutions in the US, Europe, and India, the focus will remain on optimizing the integration of large-scale biological data. By maintaining its commitment to user-friendly, high-performance computing, Pine Biotech is poised to capture a larger share of the bioinformatics market, ultimately accelerating the pace of innovation in precision medicine and biotechnology research.

See full Pine Biotech company page

See More Financial Insights